Copyright Reports & Markets. All rights reserved.

Global Heavy Ion Radiotherapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Heavy Ion Radiotherapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Heavy Ion Radiotherapy by Type
    • 1.3.1 Overview: Global Heavy Ion Radiotherapy Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Heavy Ion Radiotherapy Consumption Value Market Share by Type in 2022
    • 1.3.3 Internal Radiotherapy
    • 1.3.4 External Radiotherapy
  • 1.4 Global Heavy Ion Radiotherapy Market by Application
    • 1.4.1 Overview: Global Heavy Ion Radiotherapy Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Radiotherapy Centers
    • 1.4.4 Cancer Research Institutes
    • 1.4.5 Others
  • 1.5 Global Heavy Ion Radiotherapy Market Size & Forecast
  • 1.6 Global Heavy Ion Radiotherapy Market Size and Forecast by Region
    • 1.6.1 Global Heavy Ion Radiotherapy Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Heavy Ion Radiotherapy Market Size by Region, (2018-2029)
    • 1.6.3 North America Heavy Ion Radiotherapy Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Heavy Ion Radiotherapy Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Heavy Ion Radiotherapy Market Size and Prospect (2018-2029)
    • 1.6.6 South America Heavy Ion Radiotherapy Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Heavy Ion Radiotherapy Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Toshiba Energy
    • 2.1.1 Toshiba Energy Details
    • 2.1.2 Toshiba Energy Major Business
    • 2.1.3 Toshiba Energy Heavy Ion Radiotherapy Product and Solutions
    • 2.1.4 Toshiba Energy Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Toshiba Energy Recent Developments and Future Plans
  • 2.2 Sumitomo Heavy Industries, Ltd.
    • 2.2.1 Sumitomo Heavy Industries, Ltd. Details
    • 2.2.2 Sumitomo Heavy Industries, Ltd. Major Business
    • 2.2.3 Sumitomo Heavy Industries, Ltd. Heavy Ion Radiotherapy Product and Solutions
    • 2.2.4 Sumitomo Heavy Industries, Ltd. Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Sumitomo Heavy Industries, Ltd. Recent Developments and Future Plans
  • 2.3 Hitachi
    • 2.3.1 Hitachi Details
    • 2.3.2 Hitachi Major Business
    • 2.3.3 Hitachi Heavy Ion Radiotherapy Product and Solutions
    • 2.3.4 Hitachi Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Hitachi Recent Developments and Future Plans
  • 2.4 Nature
    • 2.4.1 Nature Details
    • 2.4.2 Nature Major Business
    • 2.4.3 Nature Heavy Ion Radiotherapy Product and Solutions
    • 2.4.4 Nature Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Nature Recent Developments and Future Plans
  • 2.5 IOPscience
    • 2.5.1 IOPscience Details
    • 2.5.2 IOPscience Major Business
    • 2.5.3 IOPscience Heavy Ion Radiotherapy Product and Solutions
    • 2.5.4 IOPscience Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 IOPscience Recent Developments and Future Plans
  • 2.6 Bayer
    • 2.6.1 Bayer Details
    • 2.6.2 Bayer Major Business
    • 2.6.3 Bayer Heavy Ion Radiotherapy Product and Solutions
    • 2.6.4 Bayer Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Bayer Recent Developments and Future Plans
  • 2.7 Mitsubishi Electric
    • 2.7.1 Mitsubishi Electric Details
    • 2.7.2 Mitsubishi Electric Major Business
    • 2.7.3 Mitsubishi Electric Heavy Ion Radiotherapy Product and Solutions
    • 2.7.4 Mitsubishi Electric Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Mitsubishi Electric Recent Developments and Future Plans
  • 2.8 Varian Medical Systems
    • 2.8.1 Varian Medical Systems Details
    • 2.8.2 Varian Medical Systems Major Business
    • 2.8.3 Varian Medical Systems Heavy Ion Radiotherapy Product and Solutions
    • 2.8.4 Varian Medical Systems Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Varian Medical Systems Recent Developments and Future Plans
  • 2.9 Accuray
    • 2.9.1 Accuray Details
    • 2.9.2 Accuray Major Business
    • 2.9.3 Accuray Heavy Ion Radiotherapy Product and Solutions
    • 2.9.4 Accuray Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Accuray Recent Developments and Future Plans
  • 2.10 Elekta
    • 2.10.1 Elekta Details
    • 2.10.2 Elekta Major Business
    • 2.10.3 Elekta Heavy Ion Radiotherapy Product and Solutions
    • 2.10.4 Elekta Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Elekta Recent Developments and Future Plans
  • 2.11 Mevion Medical Systems
    • 2.11.1 Mevion Medical Systems Details
    • 2.11.2 Mevion Medical Systems Major Business
    • 2.11.3 Mevion Medical Systems Heavy Ion Radiotherapy Product and Solutions
    • 2.11.4 Mevion Medical Systems Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Mevion Medical Systems Recent Developments and Future Plans
  • 2.12 Panacea Medical Technologies
    • 2.12.1 Panacea Medical Technologies Details
    • 2.12.2 Panacea Medical Technologies Major Business
    • 2.12.3 Panacea Medical Technologies Heavy Ion Radiotherapy Product and Solutions
    • 2.12.4 Panacea Medical Technologies Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Panacea Medical Technologies Recent Developments and Future Plans
  • 2.13 Provision Healthcare
    • 2.13.1 Provision Healthcare Details
    • 2.13.2 Provision Healthcare Major Business
    • 2.13.3 Provision Healthcare Heavy Ion Radiotherapy Product and Solutions
    • 2.13.4 Provision Healthcare Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Provision Healthcare Recent Developments and Future Plans
  • 2.14 ViewRay
    • 2.14.1 ViewRay Details
    • 2.14.2 ViewRay Major Business
    • 2.14.3 ViewRay Heavy Ion Radiotherapy Product and Solutions
    • 2.14.4 ViewRay Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 ViewRay Recent Developments and Future Plans
  • 2.15 IsoRay Medical
    • 2.15.1 IsoRay Medical Details
    • 2.15.2 IsoRay Medical Major Business
    • 2.15.3 IsoRay Medical Heavy Ion Radiotherapy Product and Solutions
    • 2.15.4 IsoRay Medical Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 IsoRay Medical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Heavy Ion Radiotherapy Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Heavy Ion Radiotherapy by Company Revenue
    • 3.2.2 Top 3 Heavy Ion Radiotherapy Players Market Share in 2022
    • 3.2.3 Top 6 Heavy Ion Radiotherapy Players Market Share in 2022
  • 3.3 Heavy Ion Radiotherapy Market: Overall Company Footprint Analysis
    • 3.3.1 Heavy Ion Radiotherapy Market: Region Footprint
    • 3.3.2 Heavy Ion Radiotherapy Market: Company Product Type Footprint
    • 3.3.3 Heavy Ion Radiotherapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Heavy Ion Radiotherapy Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Heavy Ion Radiotherapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Heavy Ion Radiotherapy Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Heavy Ion Radiotherapy Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Heavy Ion Radiotherapy Consumption Value by Type (2018-2029)
  • 6.2 North America Heavy Ion Radiotherapy Consumption Value by Application (2018-2029)
  • 6.3 North America Heavy Ion Radiotherapy Market Size by Country
    • 6.3.1 North America Heavy Ion Radiotherapy Consumption Value by Country (2018-2029)
    • 6.3.2 United States Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Heavy Ion Radiotherapy Consumption Value by Type (2018-2029)
  • 7.2 Europe Heavy Ion Radiotherapy Consumption Value by Application (2018-2029)
  • 7.3 Europe Heavy Ion Radiotherapy Market Size by Country
    • 7.3.1 Europe Heavy Ion Radiotherapy Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 7.3.3 France Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Heavy Ion Radiotherapy Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Heavy Ion Radiotherapy Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Heavy Ion Radiotherapy Market Size by Region
    • 8.3.1 Asia-Pacific Heavy Ion Radiotherapy Consumption Value by Region (2018-2029)
    • 8.3.2 China Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 8.3.5 India Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Heavy Ion Radiotherapy Consumption Value by Type (2018-2029)
  • 9.2 South America Heavy Ion Radiotherapy Consumption Value by Application (2018-2029)
  • 9.3 South America Heavy Ion Radiotherapy Market Size by Country
    • 9.3.1 South America Heavy Ion Radiotherapy Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Heavy Ion Radiotherapy Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Heavy Ion Radiotherapy Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Heavy Ion Radiotherapy Market Size by Country
    • 10.3.1 Middle East & Africa Heavy Ion Radiotherapy Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Heavy Ion Radiotherapy Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Heavy Ion Radiotherapy Market Drivers
  • 11.2 Heavy Ion Radiotherapy Market Restraints
  • 11.3 Heavy Ion Radiotherapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Heavy Ion Radiotherapy Industry Chain
  • 12.2 Heavy Ion Radiotherapy Upstream Analysis
  • 12.3 Heavy Ion Radiotherapy Midstream Analysis
  • 12.4 Heavy Ion Radiotherapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Heavy Ion Radiotherapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Heavy Ion Radiotherapy is a method of treating tumors with heavy ion radiation accelerated to 70% of the speed of light.
    This report is a detailed and comprehensive analysis for global Heavy Ion Radiotherapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Heavy Ion Radiotherapy market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Heavy Ion Radiotherapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Heavy Ion Radiotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Heavy Ion Radiotherapy market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Heavy Ion Radiotherapy
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Heavy Ion Radiotherapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Toshiba Energy, Sumitomo Heavy Industries, Ltd., Hitachi, Nature and IOPscience, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Heavy Ion Radiotherapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Internal Radiotherapy
    External Radiotherapy
    Market segment by Application
    Hospitals
    Ambulatory Radiotherapy Centers
    Cancer Research Institutes
    Others
    Market segment by players, this report covers
    Toshiba Energy
    Sumitomo Heavy Industries, Ltd.
    Hitachi
    Nature
    IOPscience
    Bayer
    Mitsubishi Electric
    Varian Medical Systems
    Accuray
    Elekta
    Mevion Medical Systems
    Panacea Medical Technologies
    Provision Healthcare
    ViewRay
    IsoRay Medical
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Heavy Ion Radiotherapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Heavy Ion Radiotherapy, with revenue, gross margin and global market share of Heavy Ion Radiotherapy from 2018 to 2023.
    Chapter 3, the Heavy Ion Radiotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Heavy Ion Radiotherapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Heavy Ion Radiotherapy.
    Chapter 13, to describe Heavy Ion Radiotherapy research findings and conclusion.

    Buy now